122 related articles for article (PubMed ID: 36328480)
1. Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum Albumin.
Wu Y; Chen L; Chen J; Xue H; He Q; Zhong D; Diao X
Drug Metab Dispos; 2023 Jan; 51(1):8-16. PubMed ID: 36328480
[TBL] [Abstract][Full Text] [Related]
2. Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS.
Li Y; Meng L; Ma Y; Li Y; Xing X; Guo C; Dong Z
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889345
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and disposition of pyrotinib in healthy male volunteers: covalent binding with human plasma protein.
Meng J; Liu XY; Ma S; Zhang H; Yu SD; Zhang YF; Chen MX; Zhu XY; Liu Y; Yi L; Ding XL; Chen XY; Miao LY; Zhong DF
Acta Pharmacol Sin; 2019 Jul; 40(7):980-988. PubMed ID: 30382184
[TBL] [Abstract][Full Text] [Related]
4. Characterization of covalent binding of tyrosine kinase inhibitors to plasma proteins.
Liu X; Feng D; Zheng M; Cui Y; Zhong D
Drug Metab Pharmacokinet; 2020 Oct; 35(5):456-465. PubMed ID: 32847720
[TBL] [Abstract][Full Text] [Related]
5. Successful salvage therapy using high-dose furmonertinib (AST2818) for non-small-cell lung cancer after Osimertinib resistance: a case report.
Cheng D; Tang S; Li D; Zhao W; Wei W; Fang C; Ji M
Anticancer Drugs; 2022 Sep; 33(8):768-772. PubMed ID: 35946524
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor.
Dickinson PA; Cantarini MV; Collier J; Frewer P; Martin S; Pickup K; Ballard P
Drug Metab Dispos; 2016 Aug; 44(8):1201-12. PubMed ID: 27226351
[TBL] [Abstract][Full Text] [Related]
7. Determination of hexahydrophthalic anhydride adducts to human serum albumin.
Kristiansson MH; Lindh CH; Jönsson BA
Biomarkers; 2003; 8(5):343-59. PubMed ID: 14602520
[TBL] [Abstract][Full Text] [Related]
8. Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans.
Meng J; Zhang H; Bao JJ; Chen ZD; Liu XY; Zhang YF; Jiang Y; Miao LY; Zhong DF
Acta Pharmacol Sin; 2022 Feb; 43(2):494-503. PubMed ID: 33927359
[TBL] [Abstract][Full Text] [Related]
9. Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.
Shi Y; Chen G; Wang X; Liu Y; Wu L; Hao Y; Liu C; Zhu S; Zhang X; Li Y; Liu J; Cao L; Cheng Y; Zhao H; Zhang S; Zang A; Cui J; Feng J; Yang N; Liu F; Jiang Y; Gu C;
Lancet Respir Med; 2022 Nov; 10(11):1019-1028. PubMed ID: 35662408
[TBL] [Abstract][Full Text] [Related]
10. Characterization of HKI-272 covalent binding to human serum albumin.
Wang J; Li-Chan XX; Atherton J; Deng L; Espina R; Yu L; Horwatt P; Ross S; Lockhead S; Ahmad S; Chandrasekaran A; Oganesian A; Scatina J; Mutlib A; Talaat R
Drug Metab Dispos; 2010 Jul; 38(7):1083-93. PubMed ID: 20400660
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Shi Y; Hu X; Zhang S; Lv D; Wu L; Yu Q; Zhang Y; Liu L; Wang X; Cheng Y; Ma Z; Niu H; Wang D; Feng J; Huang C; Liu C; Zhao H; Li J; Zhang X; Jiang Y; Gu C
Lancet Respir Med; 2021 Aug; 9(8):829-839. PubMed ID: 33780662
[TBL] [Abstract][Full Text] [Related]
12. Identification of modification sites on human serum albumin and human hemoglobin adducts with houttuynin using liquid chromatography coupled with mass spectrometry.
Deng Z; Zhong D; Chen X
Biomed Chromatogr; 2012 Nov; 26(11):1377-85. PubMed ID: 22334394
[TBL] [Abstract][Full Text] [Related]
13. Reversible covalent binding of neratinib to human serum albumin in vitro.
Chandrasekaran A; Shen L; Lockhead S; Oganesian A; Wang J; Scatina J
Drug Metab Lett; 2010 Dec; 4(4):220-7. PubMed ID: 20690900
[TBL] [Abstract][Full Text] [Related]
14. Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model.
Zou HX; Zhang YF; Zhong DF; Jiang Y; Liu F; Zhao QY; Zuo Z; Zhang YF; Yan XY
Acta Pharmacol Sin; 2022 Jul; 43(7):1865-1874. PubMed ID: 34789919
[TBL] [Abstract][Full Text] [Related]
15. Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry.
Ding A; Ojingwa JC; McDonagh AF; Burlingame AL; Benet LZ
Proc Natl Acad Sci U S A; 1993 May; 90(9):3797-801. PubMed ID: 8483897
[TBL] [Abstract][Full Text] [Related]
16. Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin: identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry.
Alvarez-Sánchez R; Divkovic M; Basketter D; Pease C; Panico M; Dell A; Morris H; Lepoittevin JP
Chem Res Toxicol; 2004 Sep; 17(9):1280-8. PubMed ID: 15377163
[TBL] [Abstract][Full Text] [Related]
17. Mapping serum albumin adducts of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by data-dependent tandem mass spectrometry.
Peng L; Dasari S; Tabb DL; Turesky RJ
Chem Res Toxicol; 2012 Oct; 25(10):2179-93. PubMed ID: 22827630
[TBL] [Abstract][Full Text] [Related]
18. Determination of Aflatoxin B1-Lysine in Pig Serum and Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Di Gregorio MC; Jager AV; Costa AA; Bordin K; Rottinhghaus GE; Petta T; Souto PC; Budiño FE; Oliveira CA
J Anal Toxicol; 2017 Apr; 41(3):236-241. PubMed ID: 27979927
[TBL] [Abstract][Full Text] [Related]
19. BTK-inhibitor drug covalent binding to lysine in human serum albumin using LC-MS/MS.
Muste C; Gu C
Drug Metab Pharmacokinet; 2022 Feb; 42():100433. PubMed ID: 34896750
[TBL] [Abstract][Full Text] [Related]
20. Using lysine adducts of human serum albumin to investigate the disposition of exogenous formaldehyde in human blood.
Regazzoni LG; Grigoryan H; Ji Z; Chen X; Daniels SI; Huang D; Sanchez S; Tang N; Sillé FC; Iavarone AT; Williams ER; Zhang L; Rappaport SM
Toxicol Lett; 2017 Feb; 268():26-35. PubMed ID: 28104429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
